Search for: "U. S. v. Baker*" Results 201 - 220 of 237
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jun 2011, 2:42 am by Andrew Lavoott Bluestone
  inBaker, Sanders, Barshay, Grossman, Fass, Muhlstock & Neuworth, LLC v Comprehensive  Mental Assessment & Medical Care, P.C.; 2011 NY Slip Op 31385(U) ;May 10, 2011 Sup Ct, Nassau County ;Docket Number: 016008/2007; Judge: Ira B. . [read post]
1 Jun 2011, 4:17 am by Zachary Spilman
We mentioned CAAF’s opinion in U.S. v. [read post]
20 May 2011, 7:42 pm by axd10
Note: From Shanghai to Globocourt: An Analysis of the "Comfort Women's" Defeat in Hwang v. [read post]
25 Apr 2011, 9:17 pm by Christine Hurt
  In 2007, a few months before Oscar, the Fifth Circuit de-certified an Enron shareholder class action suit against four banks who were involved in the Nigerian Barge transaction, alleging a violation of 10b-5 (Regents of the U. of Calif. v. [read post]
13 Apr 2011, 1:19 am by Andrew Lavoott Bluestone
  The obvious answer is "after joinder of issue", but the more real world answer is found in  Vlachos v Weil ;2011 NY Slip Op 50538(U) ;Decided on April 8, 2011 ;Supreme Court, Queens County ;Markey, J. . [read post]
20 Sep 2010, 10:38 am by Pace Law Library
Enabling urban sprawl: revisiting the Supreme Court’s seminal zoning decision Euclis v. [read post]
2 Sep 2010, 8:35 am by Stefanie Levine
Patent No. 7,619,662 owned by u-blox AG and entitled METHOD OF POSITION STAMPING A PHOTO OR VIDEO CLIP TAKEN WITH A DIGITAL CAMERA. [read post]
7 Jun 2010, 5:03 pm
"Continuous" has been defined as "[u]ninterrupted; unbroken, not intermittent or occasional; so persistently repeated at short intervals as to constitute virtually an unbroken series. [read post]
24 May 2010, 11:11 am by Marvin Ammori
Pro-BP and pro-Exxon messages might overwhelm the airwaves and newspapers while the actual support for BP's and Exxon's messages is low. [read post]
8 Apr 2010, 9:48 am by Bexis
Metabolife International, Inc., discussed the inapplicability of FDA regulatory standards to tort cases at some length:[U]se of FDA data and recommendations raises a more subtle methodological issue in a toxic tort case. [read post]